REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Citologico Citopap Ips S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers
Full name: Laboratorio Citologico Citopap Ips S.A.S. Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Citologico Citopap Ips S.A.S. is a company based in Colombia, with its head office in Barranquilla. It operates in the Ambulatory Health Care Services industry. The company was established on August 03, 2011. From the latest financial highlights, Laboratorio Citologico Citopap Ips S.A.S. reported a net sales revenue increase of 1.84% in 2023. Its’ total assets recorded a negative growth of 40.8%. The net profit margin of Laboratorio Citologico Citopap Ips S.A.S. decreased by 6.42% in 2023.

Headquarters
Cl 42 No 43 - 146 Co 204
Barranquilla; Atlantico;

Contact Details: Purchase the Laboratorio Citologico Citopap Ips S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio Citologico Citopap Ips S.A.S. report to view the information.
Incorporation Date:
August 03, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Citologico Citopap Ips S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1.84%
Total operating revenue
1.84%
Operating profit (EBIT)
-74.47%
EBITDA
-68.96%
Net Profit (Loss) for the Period
-69.2%
Total assets
-40.8%
Total equity
-42.47%
Operating Profit Margin (ROS)
-10.37%
Net Profit Margin
-6.42%
Return on Equity (ROE)
-7.51%
Quick Ratio
-1.33%
Cash Ratio
-1.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?